Saturday 17 October 2026
Export AZTA’s income statement to Excel — free account
Azenta, Inc.
AZTA Healthcare Medical Instruments & Supplies
Azenta, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $593.8 million, up 3.55% from fiscal 2024. In the quarter to June 2026, revenue grew 12.0%, EPS grew 104.4% and free cash flow fell 134.7%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three; insiders bought in the last twelve months.
34.09
2.43
−6.65%
Follow AZTA
| Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | Sep '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | 7 | 5 | 5 | 5 | 7 | 4 | 4 | 6 | 7 |
P/E ratio |
0.00 | 34.69 | 20.89 | 6.11 | 52.57 | 68.69 | 1.51 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
2.82 | 7.07 | 3.76 | 4.11 | 5.92 | 9.37 | 6.93 | 7.10 | 6.18 | 3.85 |
P/S ratio |
2.15 | 4.12 | 3.85 | 7.98 | 8.76 | 14.81 | 5.78 | 5.98 | 4.49 | 2.21 |
Altman Z″-Score (non-manufacturers) |
0.64 | 1.29 | 1.62 | 3.32 | 4.22 | 3.42 | 15.35 | 12.03 | 9.67 | 9.11 |
P/FCF ratio |
31.60 | 26.00 | 39.59 | 39.77 | 0.00 | 78.39 | 0.00 | 0.00 | 208.55 | 34.28 |
P/Operating CF |
39.78 | 62.34 | 77.86 | 81.63 | 65.69 | 280.60 | 333.20 | 116.70 | 146.42 | 605.41 |
Beneish M-Score |
(3.12) | (3.13) | (2.52) | (1.96) | (2.98) | (2.81) | (1.46) | (2.40) | (2.61) | (2.63) |
P/B ratio |
1.68 | 3.57 | 3.38 | 2.34 | 2.80 | 5.74 | 0.95 | 1.30 | 1.46 | 0.76 |
Price to Tangible BV |
3.46 | 6.85 | 6.71 | 6.68 | 6.21 | 11.36 | 1.20 | 2.26 | 2.71 | 1.42 |
EV/Sales |
1.97 | 3.94 | 3.77 | 7.13 | 8.24 | 14.45 | 2.35 | 4.22 | 3.82 | 1.72 |
EV/EBITDA |
75.40 | 48.63 | 34.25 | 292.39 | 109.94 | 215.35 | 48.30 | 141.19 | 14.68 | 31.13 |
EV/Operating CF |
21.60 | 21.59 | 32.20 | 26.20 | 84.57 | 49.53 | (2.81) | 398.54 | 44.08 | 14.14 |
EV/FCF |
28.95 | 24.87 | 38.81 | 35.52 | (1,556.10) | 76.49 | (2.41) | (69.20) | 177.53 | 26.63 |
Quick Ratio |
1.60 | 1.33 | 2.24 | 1.84 | 1.64 | 1.03 | 9.18 | 5.59 | 2.97 | 2.08 |
Current Ratio |
2.50 | 2.40 | 3.43 | 2.38 | 3.08 | 2.25 | 10.67 | 6.73 | 4.04 | 2.98 |
Net Debt/EBITDA |
(7.51) | (2.38) | (0.69) | (34.95) | (6.88) | (5.37) | (72.12) | (62.09) | (2.90) | (10.47) |
Debt/Assets |
0.00% | 0.00% | 17.90% | 3.37% | 3.23% | 2.73% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.27 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.60 | 0.73 | 0.68 | 0.26 | 0.25 | 0.30 | 0.20 | 0.17 | 0.23 | 0.29 |
Operating CF/Net income |
(0.57) | 1.54 | 0.63 | 0.21 | 0.58 | 1.35 | (0.22) | (0.40) | (0.30) | (1.29) |
Capex/Depreciation |
(0.35) | (0.45) | (0.33) | (0.43) | (0.61) | (0.81) | (1.49) | (0.51) | (0.19) | (0.57) |
Interest Coverage |
(108.62) | 35.10 | 3.30 | (2.13) | (12.43) | (15.26) | (5.39) | (1.40) | — | — |
| (11.72%) | 10.78% | 17.59% | 47.12% | 5.51% | 8.72% | 90.98% | (0.50%) | (7.67%) | (3.19%) | |
| (9.62%) | 8.62% | 12.52% | 33.50% | 4.22% | 6.56% | 77.06% | (0.44%) | (6.61%) | (2.68%) | |
ROIC |
(2.27%) | 1.77% | 2.93% | (3.47%) | (2.26%) | (1.70%) | (1.10%) | (2.53%) | (2.40%) | (1.21%) |
Return on Tangible Assets |
(29.64%) | 23.90% | 25.37% | 91.98% | 12.30% | 19.67% | 89.49% | (1.04%) | (21.07%) | (8.93%) |
Average Days of Receivables |
89.46 | 64.67 | 72.35 | 180.88 | 89.05 | 85.18 | 107.60 | 103.60 | 113.32 | 93.37 |
Research and Development Expense of Revenue |
10.19% | 7.56% | 7.43% | 5.18% | 4.59% | 4.36% | 4.96% | 5.83% | 5.50% | 5.12% |
Selling, General and Administrative Expense of Revenue |
27.49% | 26.83% | 26.45% | 48.88% | 48.97% | 49.08% | 45.27% | 47.82% | 45.86% | 44.05% |
Intangible Assets out of Total Assets |
0.41 | 0.38 | 0.32 | 0.49 | 0.43 | 0.36 | 0.19 | 0.37 | 0.39 | 0.39 |
Share Based Compensation of Revenue |
2.70% | 3.28% | 3.14% | 6.02% | 4.20% | 5.34% | 1.92% | 1.70% | 2.52% | 3.52% |
Graham Net Nets |
0.18 | 0.09 | 0.08 | 0.10 | 0.09 | 0.04 | 0.66 | 0.32 | 0.19 | 0.29 |
Graham Number |
0.00 | 13.30 | 19.44 | 46.45 | 18.07 | 24.45 | 169.40 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(7.49%) | 2.88% | 4.79% | 16.37% | 1.90% | 1.46% | 66.26% | (0.36%) | (6.13%) | (4.49%) |
Free Cash Flow Yield |
3.16% | 3.85% | 2.53% | 2.51% | (0.06%) | 1.28% | (16.93%) | (1.02%) | 0.48% | 2.92% |
Revenue per Share |
6.34 | 7.58 | 8.96 | 4.64 | 5.28 | 6.92 | 7.42 | 8.32 | 10.78 | 12.98 |
Operating CF per Share |
0.58 | 1.38 | 1.05 | 1.26 | 0.51 | 2.02 | (6.22) | 0.09 | 0.94 | 1.58 |
Capex per Share |
(0.15) | (0.18) | (0.18) | (0.33) | (0.54) | (0.71) | (1.03) | (0.60) | (0.70) | (0.74) |
Free Cash Flow per Share |
0.43 | 1.20 | 0.87 | 0.93 | (0.03) | 1.31 | (7.26) | (0.51) | 0.23 | 0.84 |
Cash per Share |
1.24 | 1.46 | 3.46 | 4.66 | 3.41 | 3.16 | 26.07 | 15.43 | 8.15 | 7.50 |
Shareholders Equity per Share |
8.08 | 8.73 | 10.18 | 15.82 | 16.50 | 17.85 | 44.91 | 38.25 | 33.25 | 37.75 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.08 | 8.73 | 10.18 | 15.82 | 16.50 | 17.85 | 44.91 | 38.25 | 33.25 | 37.75 |
Free Cash Flow |
29.51 | 83.41 | 61.38 | 67.04 | (2.06) | 97.05 | (543.48) | (33.60) | 12.35 | 38.32 |
Working Capital |
179.54 | 205.00 | 399.44 | 374.88 | 438.34 | 432.28 | 2,228.80 | 1,208.03 | 626.94 | 470.67 |
Capital Expenditures |
(10.04) | (12.82) | (12.59) | (23.86) | (39.92) | (52.80) | (77.43) | (39.44) | (37.39) | (33.86) |
Net Current Asset Value |
167.12 | 192.79 | 186.63 | 270.10 | 303.80 | 283.19 | 2,106.61 | 1,067.74 | 500.61 | 375.74 |
EV/EBIT |
0.00 | 145.09 | 75.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.07 | 0.10 | 0.10 | 0.14 | 0.07 | 0.07 | 0.06 |
Price to Operating Income |
0.00 | 151.69 | 77.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.52 | 0.50 | 0.64 | 0.55 | 0.74 | 0.50 | 0.34 | 0.38 | 1.29 | 0.39 |
Cash ROIC |
4.62% | 11.76% | 5.30% | 4.39% | (0.14%) | 6.03% | (10.22%) | (0.94%) | 0.56% | 1.85% |
Accounts Receivable Turnover |
4.50 | 5.28 | 5.78 | 2.30 | 2.98 | 4.79 | 3.92 | 3.44 | 3.43 | 3.60 |
Accounts Payable Turnover |
6.45 | 7.28 | 8.22 | 3.85 | 5.12 | 7.93 | 7.40 | 8.39 | 9.22 | 9.11 |
Inventory Turnover |
2.87 | 3.96 | 4.52 | 2.03 | 3.17 | 5.54 | 4.11 | 2.92 | 3.20 | 4.42 |
Average Days of Payables |
54.13 | 54.54 | 42.35 | 107.76 | 43.33 | 57.29 | 47.04 | 41.84 | 38.17 | 42.56 |
Days of Inventory on Hand |
121.84 | 81.52 | 91.83 | 181.87 | 62.62 | 81.68 | 104.11 | 149.84 | 81.65 | 84.56 |
Average Receivables |
96.41 | 99.92 | 109.33 | 145.40 | 130.20 | 107.33 | 141.82 | 160.15 | 167.29 | 164.97 |
Average Payables |
43.01 | 45.11 | 46.91 | 51.82 | 42.30 | 34.02 | 40.51 | 37.23 | 34.57 | 35.53 |
Average Inventory |
96.60 | 82.98 | 85.19 | 98.22 | 68.29 | 48.76 | 72.97 | 106.87 | 99.76 | 73.14 |
Average Assets |
722.30 | 726.27 | 930.94 | 1,305.63 | 1,537.63 | 1,689.39 | 2,767.82 | 3,300.92 | 2,492.99 | 2,079.92 |
Average Common Equity |
592.87 | 580.67 | 662.74 | 928.39 | 1,176.28 | 1,269.47 | 2,344.36 | 2,948.94 | 2,151.17 | 1,747.42 |
Columns are period end dates